| CAS NO: | 41340-25-4 |
| 包装 | 价格(元) |
| 10mM (in 1mL DMSO) | 询价 |
| 50mg | 询价 |
| 100mg | 询价 |
| 500mg | 询价 |
| Cas No. | 41340-25-4 |
| 别名 | 依托度酸; AY-24236 |
| 化学名 | 2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid |
| Canonical SMILES | CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O |
| 分子式 | C17H21NO3 |
| 分子量 | 287.35 |
| 溶解度 | ≥ 14.4mg/mL in DMSO |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Etodolac (Lodine) is a selective Cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 53.5 nM. Etodolac, a non-steroidal anti-inflammatory drug (NSAID), has been reported to treat osteoarthritis and rheumatoid arthritis. Etodolac was able to abolish the cell size decrease and block caspase-3/7 activity in TNFα-induced isolated rabbit articular chondrocytes [1]. However, studies have shown that etodolac at 24h could induce cell death in human malignant rhabdoid tumor cells (FRTK-1) in a dose-dependent manner. Additionally, etodolac has shown to increase caspase-8, -9 and -3 activity 3 at 24 or 48 h in FRTK-1 [2]. References: |
| 维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2026 |
